Home
>
US Stocks
>
Annexon Inc
Annexon Inc
ANNX

Annexon Inc (ANNX)

$18.799.88%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
19.39
Today Low/High
18.67 / 19.66
52 Week Low/High
$17.27 / $38.01
Market Cap
$707.79M

Company Details

Annexon is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain and eye. The company’s pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q, the initiating molecule of the classical complement pathway. Annexon is deploying a rigorous, biomarker-driven development strategy designed to improve the probability of technical success over shorter development timelines.
Organisation
Annexon Inc
Employees
48
Industry
Health Technology

Discover more

Frequently Asked Questions

What is Annexon Inc (ANNX) share price today?

Can Indians buy Annexon Inc (ANNX) shares?

How can I buy Annexon Inc (ANNX) shares from India?

Can Fractional shares of Annexon Inc (ANNX) be purchased?

What are the documents required to start investing in Annexon Inc (ANNX) stocks?

We are a SEBI registered investement advisor